XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -120.61%-85.24M | 48.37%-258.49M | 82.75%-68.78M | -122.23%-265.96M | -76.39%219.98M | 656.59%413.54M | -206.91%-500.64M | -179.43%-398.84M | ||
Net income from continuing operations | ---- | ---- | 71.97%24.34M | 108.53%23.42M | -60.96%-26.32M | -44.58%62.38M | 339.93%53.34M | -62.67%14.15M | -81.83%11.23M | -2,389.78%-16.35M |
Operating gains losses | ---- | ---- | 34.54%29.74M | 49.92%30.84M | 43.13%31.2M | -11.30%78.71M | -30.17%14.25M | 11.02%22.1M | -5.61%20.57M | -18.19%21.8M |
Depreciation and amortization | ---- | ---- | 7.51%44.58M | -2.75%40.88M | 13.25%43.98M | 0.24%166.22M | -6.72%43.89M | -6.53%41.46M | 7.99%42.03M | 9.46%38.83M |
Deferred tax | ---- | ---- | --0 | --0 | ---136K | 78.80%-5.2M | 78.71%-5.2M | --0 | --0 | --0 |
Other non cash items | ---- | ---- | -181.14%-246.77M | 35.49%-339.27M | 103.47%10.38M | -157.09%-459.4M | -92.35%61.85M | 293.96%304.11M | -68.96%-525.92M | -164.50%-299.44M |
Change In working capital | ---- | ---- | 2,319.27%16.57M | 41.03%-40.16M | 0.47%-179.68M | -26.93%-260.9M | -177.22%-12.95M | 101.04%685K | -109.83%-68.1M | -45.33%-180.53M |
-Change in receivables | ---- | ---- | 48.12%-14.52M | -0.87%-53.19M | 41.12%-62.07M | -286.37%-312.57M | -162.90%-126.42M | -5.45%-27.99M | -138.94%-52.73M | -767.16%-105.42M |
-Change in payables and accrued expense | ---- | ---- | 394.98%66.49M | 299.97%22.69M | -53.73%-109.4M | 132.40%46.31M | 3,422.13%115.39M | -32.33%13.43M | 80.10%-11.35M | 34.76%-71.16M |
-Change in other current assets | ---- | ---- | -195.73%-40.45M | 278.43%27.53M | 336.49%23.97M | 235.49%45.11M | -73.67%5.71M | 198.59%42.26M | -43.23%7.27M | 59.34%-10.14M |
-Change in other current liabilities | ---- | ---- | 118.70%5.05M | -229.18%-37.18M | -620.15%-32.19M | -177.02%-39.75M | -119.11%-7.62M | -67.94%-27.02M | -133.40%-11.3M | 202.91%6.19M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 96.26%-9.94M | 83.01%402.58M | -120.61%-85.24M | 48.37%-258.49M | 82.75%-68.78M | -122.23%-265.96M | -76.39%219.98M | 656.59%413.54M | -206.91%-500.64M | -179.43%-398.84M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -111.21%-10.68M | 40.06%-9.27M | 93.77%-7.35M | -116.12%-49.75M | 47.96%-11.54M | 523.28%95.31M | 78.96%-15.46M | -127.66%-118.06M | ||
Net PPE purchase and sale | ---- | ---- | 9.87%-9.18M | 40.06%-9.27M | 61.25%-7.04M | 10.98%-55.36M | 47.96%-11.54M | 54.70%-10.19M | -74.49%-15.46M | -109.64%-18.17M |
Net business purchase and sale | ---- | ---- | --0 | --0 | --0 | -55.47%-99.89M | --0 | --0 | --0 | ---99.89M |
Net investment purchase and sale | ---- | ---- | --0 | --0 | ---312K | -75.75%105.5M | --0 | 329,790.63%105.5M | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 32.80%-33.43M | 46.89%-6.13M | -111.21%-10.68M | 40.06%-9.27M | 93.77%-7.35M | -116.12%-49.75M | 47.96%-11.54M | 523.28%95.31M | 78.96%-15.46M | -127.66%-118.06M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 119.36%102.07M | -35.06%307.24M | -88.74%56.14M | 117.93%261.46M | 79.76%-183.01M | -1,171.87%-527.28M | 541.06%473.1M | 173.60%498.65M | ||
Net issuance payments of debt | ---- | ---- | 144.30%217.94M | -25.67%374.43M | -76.75%119.8M | 134.29%361.23M | 81.13%-165.83M | -370.68%-492.02M | 91.64%503.77M | 183.25%515.3M |
Net common stock issuance | ---- | ---- | -373.59%-89.55M | -315.44%-55.51M | ---37.16M | 87.30%-37.43M | 62.10%-5.16M | 82.04%-18.91M | 90.79%-13.36M | --0 |
Cash dividends paid | ---- | ---- | 2.69%-5.1M | 0.69%-5.19M | -0.33%-5.23M | -16.57%-20.91M | -0.75%-5.22M | 2.11%-5.25M | 5.02%-5.23M | -175.49%-5.22M |
Net other financing activities | ---- | ---- | -90.92%-21.22M | 46.26%-6.5M | -86.04%-21.26M | 55.20%-41.43M | -8.24%-6.8M | 49.38%-11.11M | 68.64%-12.09M | 55.55%-11.43M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -65.76%89.53M | -105.41%-375.92M | 119.36%102.07M | -35.06%307.24M | -88.74%56.14M | 117.93%261.46M | 79.76%-183.01M | -1,171.87%-527.28M | 541.06%473.1M | 173.60%498.65M |
Net cash flow | ||||||||||
Beginning cash position | -17.33%258.71M | 21.89%284.34M | 10.53%278.2M | -19.00%238.71M | -17.33%258.71M | 17.43%312.95M | -24.15%233.28M | -29.13%251.7M | -43.10%294.7M | 17.43%312.95M |
Current changes in cash | 185.09%46.16M | -19.28%20.53M | 133.31%6.14M | 191.84%39.49M | -9.58%-20M | -216.78%-54.25M | 369.73%25.43M | 61.30%-18.43M | 73.59%-43M | -107.26%-18.25M |
End cash Position | 17.84%304.87M | 17.84%304.87M | 21.89%284.34M | 10.53%278.2M | -19.00%238.71M | -17.33%258.71M | -17.33%258.71M | -24.15%233.28M | -29.13%251.7M | -43.10%294.7M |
Free cash flow | 96.91%-9.94M | 93.14%402.58M | -123.78%-95.93M | 48.12%-267.75M | 81.82%-75.83M | -128.33%-321.32M | -77.08%208.44M | 516.75%403.35M | -200.09%-516.1M | -184.50%-417.01M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |